Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 23 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Lotus Eye Hospital & Institute Ltd

About the Company - Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 38.91 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesS.F No.770/12, Avinashi Road, Coimbatore Tamil Nadu 641014companysecretary@lotuseye.org
http://www.lotuseye.org
Management
NamePosition Held
Dr. Kavetha SundaramoorthyChairman
Ms. Sangeetha SundaramoorthyManaging Director
Dr. K S RamalingamWholeTime Director & CEO
Mr. D R KaarthikeyanDirector
Dr. Yogesh ShahDirector
CA. M AlagiriswamyDirector
Dr. S NatesanDirector
Mr. Karthik VeeramaniDirector
CA. Perumalsamy MahendranDirector

Basic Stock Data of Lotus Eye Hospital & Institute Ltd

Last Updated: June 17, 2024, 8:26 pm

Market Cap 129 Cr.
Current Price 62.2
High / Low111/44.1
Stock P/E44.4
Book Value 28.6
Dividend Yield0.80 %
ROCE6.97 %
ROE4.97 %
Face Value 10.0
PEG Ratio1.45

Lotus Eye Hospital & Institute Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales9.8710.575.9210.8111.6110.5711.8711.8612.1411.1712.5712.7312.03
Expenses8.208.815.758.729.269.339.5510.1010.039.7810.1810.9210.45
Operating Profit1.671.760.172.092.351.242.321.762.111.392.391.811.58
OPM %16.92%16.65%2.87%19.33%20.24%11.73%19.55%14.84%17.38%12.44%19.01%14.22%13.13%
Other Income0.200.190.170.210.220.280.240.230.320.360.290.280.34
Interest0.020.010.020.040.040.030.030.030.020.020.020.010.04
Depreciation0.590.590.530.600.630.750.680.750.770.780.730.890.98
Profit before tax1.261.35-0.211.661.900.741.851.211.640.951.931.190.90
Tax %15.87%17.78%4.76%24.70%26.84%27.03%26.49%24.79%29.88%31.58%27.98%28.57%26.67%
Net Profit1.051.11-0.201.251.390.541.370.901.160.651.380.850.66
EPS in Rs0.500.53-0.100.600.670.260.660.430.560.310.660.410.32

Last Updated: June 4, 2024, 6:26 pm

Lotus Eye Hospital & Institute Ltd Quarterly Chart

Lotus Eye Hospital & Institute Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales26.2329.1128.6929.9031.1333.9638.0238.4340.5532.3538.9047.0348.61
Expenses24.6425.5125.4027.7227.1430.6333.6835.2136.5728.7332.9839.3540.91
Operating Profit1.593.603.292.183.993.334.343.223.983.625.927.687.70
OPM %6.06%12.37%11.47%7.29%12.82%9.81%11.42%8.38%9.82%11.19%15.22%16.33%15.84%
Other Income0.360.640.390.460.580.680.910.680.210.840.881.151.25
Interest0.050.050.040.100.160.150.180.210.240.140.210.200.07
Depreciation4.143.733.544.764.443.443.373.062.502.332.502.983.17
Profit before tax-2.240.460.10-2.22-0.030.421.700.631.451.994.095.655.71
Tax %-0.45%8.70%60.00%10.81%400.00%-7.14%-2.35%-12.70%26.90%21.11%27.14%27.79%
Net Profit-2.250.420.04-1.980.100.441.750.711.061.572.984.084.04
EPS in Rs-1.080.200.02-0.950.050.210.840.340.510.751.431.961.94
Dividend Payout %0.00%0.00%0.00%0.00%0.00%236.36%59.43%0.00%0.00%66.24%34.90%25.49%

Lotus Eye Hospital & Institute Ltd Profit & Loss Yearly Chart

Lotus Eye Hospital & Institute Ltd Growth

Compounded Sales Growth
10 Years:5%
5 Years:5%
3 Years:14%
TTM:3%
Compounded Profit Growth
10 Years:54%
5 Years:33%
3 Years:24%
TTM:-29%
Stock Price CAGR
10 Years:21%
5 Years:26%
3 Years:12%
1 Year:-23%
Return on Equity
10 Years:3%
5 Years:5%
3 Years:6%
Last Year:5%

Last Updated: June 17, 2024, 2:56 pm

Lotus Eye Hospital & Institute Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital20.8020.8020.8020.8020.8020.8020.8020.8020.8020.8020.8020.8020.80
Reserves30.1130.5330.5728.5928.6929.2629.8429.3230.4631.9033.8136.7837.95
Borrowings0.430.260.180.830.660.480.290.220.320.401.240.670.00
Other Liabilities4.725.317.016.204.684.407.286.186.536.125.754.938.06
Total Liabilities56.0656.9058.5656.4254.8354.9458.2156.5258.1159.2261.6063.1866.81
Fixed Assets47.7845.3146.9447.0443.5741.3242.5244.1442.6740.5444.0744.1846.99
CWIP0.000.180.360.270.420.650.290.290.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets8.2811.4111.269.1110.8412.9715.4012.0915.4418.6817.5319.0019.82
Total Assets56.0656.9058.5656.4254.8354.9458.2156.5258.1159.2261.6063.1866.81

Lotus Eye Hospital & Institute Ltd Reserves and Borrowings Chart

Lotus Eye Hospital & Institute Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 2.283.714.412.373.382.975.784.204.972.734.414.39
Cash from Investing Activity -3.29-1.20-5.05-4.65-0.85-1.06-3.86-4.01-0.680.49-3.94-2.19
Cash from Financing Activity 0.15-0.16-0.771.87-0.58-0.25-1.51-1.410.13-0.32-1.58-1.71
Net Cash Flow-0.862.35-1.41-0.401.961.660.41-1.224.422.90-1.100.49

Lotus Eye Hospital & Institute Ltd Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days3.894.964.275.987.3110.947.225.948.355.829.089.54
Inventory Days135.42166.70121.54113.2560.2279.23128.20124.42138.82150.03153.6076.48
Days Payable160.79130.52125.08105.5187.32129.95167.37170.41220.72231.21173.4282.43
Cash Conversion Cycle-21.4841.140.7313.72-19.79-39.78-31.95-40.05-73.54-75.37-10.743.58
Working Capital Days0.25-13.10-19.90-8.56-8.92-26.02-14.53-21.33-20.99-10.9812.345.68
ROCE %0.99%0.27%-4.23%0.24%1.19%3.63%1.66%4.67%3.92%7.91%10.25%

Lotus Eye Hospital & Institute Ltd Financial Efficiency Indicators Chart

Lotus Eye Hospital & Institute Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters57.74%57.74%57.74%57.74%57.74%57.74%57.88%58.14%58.17%58.44%57.58%56.58%
Public42.26%42.26%42.26%42.26%42.26%42.26%42.12%41.86%41.83%41.56%42.43%43.42%
No. of Shareholders5,9636,3306,1756,2266,8307,0317,4167,4167,3457,4257,6608,314

Lotus Eye Hospital & Institute Ltd Shareholding Pattern Chart

No. of Lotus Eye Hospital & Institute Ltd Shareholders

This stock is not held by any mutual fund

Lotus Eye Hospital & Institute Ltd ROCE Trend

Lotus Eye Hospital & Institute Ltd EPS Trend

Lotus Eye Hospital & Institute Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)1.401.961.440.750.51
Diluted EPS (Rs.)1.401.961.440.750.51
Cash EPS (Rs.)3.193.392.641.871.71
Book Value[Excl.RevalReserv]/Share (Rs.)28.5727.6926.2625.3424.65
Book Value[Incl.RevalReserv]/Share (Rs.)28.5727.6926.2625.3424.65
Dividend / Share (Rs.)0.000.500.500.500.00
Revenue From Operations / Share (Rs.)23.1822.6218.7115.5619.50
PBDIT / Share (Rs.)3.774.203.242.072.27
PBIT / Share (Rs.)1.972.772.030.951.07
PBT / Share (Rs.)1.932.721.970.950.69
Net Profit / Share (Rs.)1.401.961.440.750.51
PBDIT Margin (%)16.2418.5617.3013.3011.62
PBIT Margin (%)8.5112.2210.876.105.47
PBT Margin (%)8.3212.0110.526.153.58
Net Profit Margin (%)6.048.667.674.842.62
Return on Networth / Equity (%)4.907.085.462.972.07
Return on Capital Employeed (%)6.799.917.573.694.23
Return On Assets (%)4.376.454.842.641.82
Asset Turnover Ratio (%)0.740.750.640.550.70
Current Ratio (X)2.252.832.242.341.75
Quick Ratio (X)1.742.301.842.031.41
Inventory Turnover Ratio (X)2.813.283.192.612.66
Interest Coverage Ratio (X)80.4289.4752.5666.3566.88
Interest Coverage Ratio (Post Tax) (X)30.8642.8024.3823.9125.92
Enterprise Value (Cr.)110.46112.37102.1077.2241.44
EV / Net Operating Revenue (X)2.292.392.622.391.02
EV / EBITDA (X)14.1012.8715.1717.938.79
MarketCap / Net Operating Revenue (X)2.442.572.852.691.19
Price / BV (X)1.982.102.031.650.94
Price / Net Operating Revenue (X)2.442.572.852.691.19
EarningsYield0.020.030.020.010.02

Lotus Eye Hospital & Institute Ltd Profitability Ratios (%)

Lotus Eye Hospital & Institute Ltd Liquidity Ratios

Lotus Eye Hospital & Institute Ltd Liquidity Ratios (%)

Lotus Eye Hospital & Institute Ltd Interest Coverage Ratios (%)

Lotus Eye Hospital & Institute Ltd Valuation Ratios

Fair Value

Fair Value: 63.62

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 2.28% compared to the current price 62.2

Intrinsic Value: 83.10

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 33.60% compared to the current price ₹62.2

Last 5 Year EPS CAGR: 30.63%

*Investments are subject to market risks

Strength and Weakness of Lotus Eye Hospital & Institute Ltd Stock

StrengthWeakness
  1. The stock has a low average Working Capital Days of -10.51, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -21.13, which is a positive sign.
  3. The company has higher reserves (31.37 cr) compared to borrowings (0.46 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (35.61 cr) and profit (1.36 cr) over the years.
  1. The stock has a low average ROCE of 2.54%, which may not be favorable.

FAQ

What is the latest fair value of Lotus Eye Hospital & Institute Ltd?

The latest fair value of Lotus Eye Hospital & Institute Ltd is ₹63.62.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd?

The Market Cap of Lotus Eye Hospital & Institute Ltd is 129 Cr..

What is the current Stock Price of Lotus Eye Hospital & Institute Ltd as on 23 June 2024?

The current stock price of Lotus Eye Hospital & Institute Ltd as on 23 June 2024 is ₹62.2.

What is the High / Low of Lotus Eye Hospital & Institute Ltd stocks in FY 2024?

In FY 2024, the High / Low of Lotus Eye Hospital & Institute Ltd stocks is 111/44.1.

What is the Stock P/E of Lotus Eye Hospital & Institute Ltd?

The Stock P/E of Lotus Eye Hospital & Institute Ltd is 44.4.

What is the Book Value of Lotus Eye Hospital & Institute Ltd?

The Book Value of Lotus Eye Hospital & Institute Ltd is 28.6.

What is the Dividend Yield of Lotus Eye Hospital & Institute Ltd?

The Dividend Yield of Lotus Eye Hospital & Institute Ltd is 0.80 %.

What is the ROCE of Lotus Eye Hospital & Institute Ltd?

The ROCE of Lotus Eye Hospital & Institute Ltd is 6.97 %.

What is the ROE of Lotus Eye Hospital & Institute Ltd?

The ROE of Lotus Eye Hospital & Institute Ltd is 4.97 %.

What is the Face Value of Lotus Eye Hospital & Institute Ltd?

The Face Value of Lotus Eye Hospital & Institute Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lotus Eye Hospital & Institute Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE